Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation

Arroyo, 2000, Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem, J Hepatol, 32, 157, 10.1016/S0168-8278(00)80423-7 Iwakiri, 2006, The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule, Hepatology, 43, S121, 10.1002/hep.20993 Zardi, 2010, Cirrhotic cardiomyopathy, J Am Coll Cardiol, 56, 539, 10.1016/j.jacc.2009.12.075 Moller, 2002, Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease, Heart, 87, 9, 10.1136/heart.87.1.9 Moller, 2010, Cirrhotic cardiomyopathy, J Hepatol, 53, 179, 10.1016/j.jhep.2010.02.023 Ma, 1996, Cirrhotic cardiomyopathy: getting to the heart of the matter, Hepatology, 24, 451, 10.1002/hep.510240226 Liu, 2017, Cirrhotic cardiomyopathy: implications for liver transplantation, Liver Transpl, 23, 826, 10.1002/lt.24768 Ortiz-Olvera, 2011, Anatomical cardiac alterations in liver cirrhosis: an autopsy study, Ann Hepatol, 10, 321, 10.1016/S1665-2681(19)31544-3 Merli, 2013, Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease, Eur J Int Med, 24, 172, 10.1016/j.ejim.2012.08.007 Karagiannakis, 2013, Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia, Dig Dis Sci, 58, 3029, 10.1007/s10620-013-2693-y Krag, 2010, Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites, Gut, 59, 105, 10.1136/gut.2009.180570 Arroyo, 2007, Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome, J Hepatol, 46, 935, 10.1016/j.jhep.2007.02.001 Torregrosa, 2005, Cardiac alterations in cirrhosis: reversibility after liver transplantation, J Hepatol, 42, 68, 10.1016/j.jhep.2004.09.008 Lee, 2003, Cardiac dysfunction in spontaneous bacterial peritonitis: A manifestation of cirrhotic cardiomyopathy?, Hepatology, 38, 1089, 10.1053/jhep.2003.50489 Ruiz-del-Arbol, 2005, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 42, 439, 10.1002/hep.20766 Groszmann, 2005, Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis, N Engl J Med, 353, 2254, 10.1056/NEJMoa044456 Krag, 2012, The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease, Gut, 61, 967, 10.1136/gutjnl-2011-301348 Serste, 2010, Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites, Hepatology, 52, 1017, 10.1002/hep.23775 Bossen, 2015, Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three RCTs with 1198 patients, Hepatology, 10.1016/S0168-8278(15)30087-8 Chirapongsathorn, 2016, Nonselective beta-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 14, 10.1016/j.cgh.2016.01.012 Onali, 2017, Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites, Liver Int, 37, 1334, 10.1111/liv.13409 Leithead, 2015, Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation, Gut, 64, 1111, 10.1136/gutjnl-2013-306502 Glantz, 1978, Factors which affect the diastolic pressure–volume curve, Circul Res, 42, 171, 10.1161/01.RES.42.2.171 Moller, 2016, Diastolic dysfunction in cirrhosis, Heart Fail Rev, 21, 599, 10.1007/s10741-016-9552-9 Garg, 2013, Echocardiography in liver transplant candidates, JACC Cardiovasc Imaging, 6, 105, 10.1016/j.jcmg.2012.11.002 Nagueh, 2009, Recommendations for the evaluation of left ventricular diastolic function by echocardiography, Eur J Echocardiogr, 10, 165, 10.1093/ejechocard/jep007 Kazankov, 2011, Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging, Liver Int, 31, 534, 10.1111/j.1478-3231.2011.02468.x Cotter, 2016, Hemodynamic measures in patients with acute heart failure-is it all that it seems to be?, J Card Fail, 22, 190, 10.1016/j.cardfail.2015.12.010 Cotter, 2003, Role of cardiac power in heart failure, Curr Opin Cardiol, 18, 215, 10.1097/00001573-200305000-00007 Choi, 2010, Noninvasive assessment of left ventricular stroke work index in patients with severe mitral regurgitation: correlation with invasive measurement and exercise capacity, Echocardiography, 27, 1161, 10.1111/j.1540-8175.2010.01222.x Bouchard, 2004, Poor correlation between hemodynamic and echocardiographic indexes of left ventricular performance in the operating room and intensive care unit, Crit Care Med, 32, 644, 10.1097/01.CCM.0000108877.92124.DF Turco, 2018, Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis, J Hepatol, 68, 949, 10.1016/j.jhep.2017.12.027 Payance, 2016, Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis, Aliment Pharmacol Ther, 43, 966, 10.1111/apt.13577 Antoine, 2017, Organ transplantation in France, Transplantation, 101, 445, 10.1097/TP.0000000000001510 Durand, 2019, Liver transplantation in France, Liver Transpl, 25, 763, 10.1002/lt.25419 Martin, 1999, Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients, Crit Care Med, 27, 1708, 10.1097/00003246-199909000-00002 Austin, 2016, Introduction to the analysis of survival data in the presence of competing Risks, Circulation, 133, 601, 10.1161/CIRCULATIONAHA.115.017719 Contal, 1999, An application of changepoint methods in studying the effect of age on survival in breast cancer, Comput Stat, 30, 253 Arroyo, 1996, Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club, Hepatology, 23, 164, 10.1002/hep.510230122 Serste, 2011, Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study, J Hepatol, 55, 794, 10.1016/j.jhep.2011.01.034 Kim, 2017, Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates, Liver Transpl, 23, 733, 10.1002/lt.24744 Mandorfer, 2014, Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis, Gastroenterology, 146, 10.1053/j.gastro.2014.03.005 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 D'Amico, 2016, Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?, Hepatology, 63, 1771, 10.1002/hep.28502 Bilchick, 2017, Clinical impact of changes in hemodynamic indices of contractile function during treatment of acute decompensated heart failure, J Card Fail Cales, 1989, Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension, Br J Clin Pharmacol, 27, 763, 10.1111/j.1365-2125.1989.tb03438.x Ommen, 2000, Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study, Circulation, 102, 1788, 10.1161/01.CIR.102.15.1788